Introduction
Implantable Cardioverter Defibrillators (ICD) are considered to be the treatment of choice for primary and secondary prevention of sudden cardiac death. However, the therapy is burdened by inappropriate ICD shocks (for example for supraventricular tachyarrhythmias) which reduce patient's quality of life and acceptance of the device, although dual chamber (DC) ICD have access to atrial and ventricular information for tachyarrhythmia discrimination. Recent studies have failed to show a clear benefit in reducing inappropriate shocks by these devices [1] [2] [3] . But adequately powered trials with a long-term follow-up are scarce.
Methods
Patients (pts) were recruited in 54 international centres and supplied with a DC ICD. A total of 453 pts were randomised to receive either standard SC programming or optimised DC programming [4] . Optimised DC programming was defined by the activation of the discrimination algorithm (PARAD+) and a mode (SafeR) to minimise ventricular pacing (Vp). ICD indications were primary (75%) or secondary (25%) prevention of sudden cardiac death; pts were aged 63±11 years (86% males). For the both groups, zones of arrhythmia detection were set with the following inferior cutoffs: VF 240; Fast VT 200; VT 170; slow VT 120 bpm. ATP and/or shock therapies were recommended to be activated in all these zones. Pts' outcome measures were the occurrence of inappropriate shocks, all-cause mortality and cardiovascular morbidity. 
Results

